1. P276 Cardiovascular safety of extrafine single inhaler triple combination of beclometasone dipropionate, formoterol fumarate, and glycopyrronium bromide in copd: results of safety analysis from the trilogy and trinity studies. (15th November 2017) Authors: Scuri, M; Singh, D; Papi, A; Corradi, M; Montagna, I; Francisco, C; Cohuet, G; Vezzoli, S; Muraro, A; Petruzzelli, S; Vestbo, J Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P271 Effect of extrafine single inhaler triple therapy on lung function and use of rescue medication: results from the trinity study. (15th November 2017) Authors: Scuri, M; Vestbo, J; Papi, A; Corradi, M; Montagna, I; Francisco, C; Cohuet, G; Vezzoli, S; Muraro, A; Petruzzelli, S; Singh, D Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P273 Association of incident pneumonia and exacerbations with extrafine triple therapy in one single inhaler in copd patients: a post-hoc analysis from trilogy and trinity studies. (15th November 2017) Authors: Scuri, M; Vestbo, J; Papi, A; Corradi, M; Spinola, M; Montagna, I; Francisco, C; Cohuet, G; Vezzoli, S; Muraro, A; Petruzzelli, S; Singh, D Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗